Company Information
Industry 制造业
Company Introduction 金宇生物技术股份有限公司是一家以生物药品制造为主,房地产开发、羊绒纺织和农牧业资源综合开发利用为辅业的发展格局的公司.公司全资子公司内蒙古生物药品厂是内蒙古自治区唯一一家生产兽用生物制品和畜禽疫苗制品的企业,行业排名第二位,是农业部指定的三个牛羊猪特种疫苗生产基地之一,口蹄疫疫苗市场占有率曾达到全国第一.房地产业务主要集中在呼和浩特市,发展稳健.羊绒业务曾是公司的支柱之一,主要生产"山丹牌"丝绒纱、羊绒衫、驼绒衫裤等.此外,公司旗下内蒙古金宇生物制品有限责任公司是实施亚麻籽综合开发项目的绿色食品生产企业。
Main Business 生物药品制造、房地产开发、羊绒纺织、生物技术开发应用
Legal Representative 张翀宇
Top Executives
董事长:张翀宇
副董事长:张竞
董事:彭敏
独立董事:张桂红,吴振平,申嫦娥,耿明
Top 5 Shareholder
Shareholder name Nature Holding Date
内蒙古金宇生物控股有限公司流通A股10.92%30/10/2024
伟星资产管理(上海)有限公司-宁波梅山保税港区星棋道和股权投资合伙企业(有限合伙)流通A股3.78%30/10/2024
上海淳韬投资管理有限公司-淳韵价值一号证券投资私募基金流通A股3.60%30/10/2024
张翀宇流通A股2.05%30/10/2024
浙商银行股份有限公司-国泰中证畜牧养殖交易型开放式指数证券投资基金流通A股1.58%30/10/2024
Company Secretary 彭敏
Solicitors 北京市中伦律师事务所
Auditors 立信会计师事务所(特殊普通合伙)
Tel No 0471-6539434
Fax No 0471-8086060
Website www.jinyu.com.cn
Email stock@jinyu.com.cn
Company Address
Register: 内蒙古自治区呼和浩特市经济技术开发区沙尔沁工业园区金宇大街1号
Office: 内蒙古自治区呼和浩特市经济技术开发区沙尔沁工业园区金宇大街1号
Listing Date 15/01/1999
Shares Capital
Shares Capital: 1,120,369,226
Total A Share: 1,120,369,226
Listed A Share: 1,120,369,226
Non-tradable A Share: 0
Other Share: 0
Total B Share: 0
Total H Share: 0
EPS(RMB)* ¥ 0.260
DPS(RMB)* ¥ 0.080
NBV Per Share(RMB)* ¥ 4.790
Market Capitalization(RMB) 7.988B
Smiley face Only Chinese content is avaliable
N
/
N
 : Eligible Stock for SH-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SH-HK Ex-Northbound trade (sell only)
N
/
N
 : Eligible Stock for SZ-HK Northbound trade (For all investors/ For institutional professional investors only)
N
 : Eligible Stock for SZ-HK Ex-Northbound trade (sell only)
* Unadjusted Data
Information provided by: etnet
Terms and Conditions
Risk Disclosure:
The prices of securities may fluctuate, sometimes dramatically. The price of a security may move up or down, and may become valueless. It is as likely that losses will be incurred rather than profit made as a result of buying and selling securities. The information is for reference only, it does not constitute any offer, solicitation, recommendation, comment or any guarantee to the purchase or sale of any investment product or service. Customers should not make any investment decisions based on this information alone.
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.